News
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option.
Hosted on MSN1mon
A new COVID-19 variant, vaccine changes: What to know in 2025 - MSNCOVID-19 is remains a public health concern five years after the start of the pandemic. What to know about vaccines, variants and more.
Though the government may no longer recommend COVID vaccines for many children and pregnant people, you doctor still might.
Wondering about the latest vaccine recommendations to protect against COVID-19? It's complicated.
May 22, 2025 – COVID-19 vaccines are making headlines, as government officials appear poised to scale back recommendations and the FDA approved the Novavax vaccine with new limitations.
Health care providers may be able to provide the Covid-19 vaccine “off-label” – but they’d need to have the vaccine in stock, which has become increasingly uncommon.
Which COVID-19 variants should be targeted in the next round of COVID vaccines? The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) will be addressing that issue in a ...
the only people who will be New changes say COVID-19 vaccines are only for those over 65 and for people with existing health problems.
A majority of the agency's COVID-19 vaccine work group now backs narrower "risk-based" recommendations.
Since 2023, federal health officials have recommended an annual COVID-19 shot for most people, and vaccine makers have not needed to conduct additional tests on each year’s updated vaccine.
The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.
COVID-19 is remains a public health concern five years after the start of the pandemic. What to know about vaccines, variants and more.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results